No doubt,and Amgn still stole the NEO partnership,monetarily,and now it`s a total free agent. The money upfront can be more then double what Amgn gave us. Not only that but BmY needs us to get market share back from Merck,potentially,,so they should be motivated to bid against Merck for a partnership with Adxs. Can we still have that bidding war,that I talked about for years? Maybe so,because Merck and BMY have the CPI,and really deep pockets of cash.
Market Data 
Markets 
AI
